$TECH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIO-TECHNE Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIO-TECHNE Corp. Get notifications about new insider transactions in BIO-TECHNE Corp for free.
Page: < prev 1 2 3 4 5 6 7 ... 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 28 2019 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Director | Grant | A | 0.00 | 495 | 0 | 1,748 | 1.3 K to 1.7 K (+39.51 %) |
Oct 28 2019 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Option Exercise | A | 201.64 | 2,011 | 405,498 | 2,011 | |
Oct 28 2019 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Grant | A | 0.00 | 495 | 0 | 5,221 | 4.7 K to 5.2 K (+10.47 %) |
Oct 28 2019 | TECH | BIO-TECHNE Corp | VESSEY RUPERT | Director | Option Exercise | A | 201.64 | 2,011 | 405,498 | 2,011 | |
Oct 28 2019 | TECH | BIO-TECHNE Corp | VESSEY RUPERT | Director | Grant | A | 0.00 | 495 | 0 | 642 | 147 to 642 (+336.73 %) |
Oct 28 2019 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Option Exercise | A | 201.64 | 2,011 | 405,498 | 2,011 | |
Oct 28 2019 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Grant | A | 0.00 | 495 | 0 | 4,721 | 4.2 K to 4.7 K (+11.71 %) |
Oct 28 2019 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Option Exercise | A | 201.64 | 2,011 | 405,498 | 2,011 | |
Oct 28 2019 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Grant | A | 0.00 | 495 | 0 | 5,721 | 5.2 K to 5.7 K (+9.47 %) |
Oct 28 2019 | TECH | BIO-TECHNE Corp | Seth Alpna | Director | Option Exercise | A | 201.64 | 2,011 | 405,498 | 2,011 | |
Oct 28 2019 | TECH | BIO-TECHNE Corp | Seth Alpna | Director | Grant | A | 0.00 | 495 | 0 | 1,748 | 1.3 K to 1.7 K (+39.51 %) |
Oct 28 2019 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Option Exercise | A | 201.64 | 2,011 | 405,498 | 2,011 | |
Oct 28 2019 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Grant | A | 0.00 | 495 | 0 | 4,021 | 3.5 K to 4 K (+14.04 %) |
Oct 28 2019 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Option Exercise | A | 201.64 | 2,011 | 405,498 | 2,011 | |
Oct 28 2019 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Grant | A | 0.00 | 495 | 0 | 9,221 | 8.7 K to 9.2 K (+5.67 %) |
Sep 11 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | P | 185.00 | 100 | 18,500 | 100 | 0 to 100 |
Sep 11 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | P | 185.00 | 100 | 18,500 | 100 | 0 to 100 |
Aug 21 2019 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | M | 0.00 | 2,287 | 0 | 0 | |
Aug 21 2019 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Payment of Exercise | F | 197.57 | 900 | 177,813 | 1,387 | 2.3 K to 1.4 K (-39.35 %) |
Aug 21 2019 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Buy | M | 0.00 | 2,287 | 0 | 2,287 | 0 to 2.3 K |
Aug 21 2019 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 0.00 | 4,925 | 0 | 0 | |
Aug 21 2019 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Payment of Exercise | F | 197.57 | 2,424 | 478,910 | 6,883 | 9.3 K to 6.9 K (-26.04 %) |
Aug 21 2019 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 0.00 | 4,925 | 0 | 9,307 | 4.4 K to 9.3 K (+112.39 %) |
Aug 21 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 0.00 | 24,979 | 0 | 0 | |
Aug 21 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 0.00 | 24,979 | 0 | 135,856 | 110.9 K to 135.9 K (+22.53 %) |
Aug 21 2019 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | M | 0.00 | 1,759 | 0 | 0 | |
Aug 21 2019 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Payment of Exercise | F | 197.57 | 745 | 147,190 | 3,203 | 3.9 K to 3.2 K (-18.87 %) |
Aug 21 2019 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Buy | M | 0.00 | 1,759 | 0 | 3,948 | 2.2 K to 3.9 K (+80.36 %) |
Aug 15 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 67.46 | 7,410 | 499,879 | 57,590 | |
Aug 15 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 67.46 | 7,410 | 499,879 | 110,877 | 103.5 K to 110.9 K (+7.16 %) |
Aug 09 2019 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Buy | P | 191.06 | 500 | 95,530 | 8,726 | 8.2 K to 8.7 K (+6.08 %) |
Aug 09 2019 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | A | 190.41 | 21,265 | 4,049,069 | 21,265 | |
Aug 09 2019 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | A | 190.41 | 15,948 | 3,036,659 | 15,948 | |
Aug 09 2019 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | A | 0.00 | 3,151 | 0 | 3,151 | |
Aug 09 2019 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 190.41 | 13,290 | 2,530,549 | 13,290 | |
Aug 09 2019 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 190.41 | 9,968 | 1,898,007 | 9,968 | |
Aug 09 2019 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 0.00 | 1,969 | 0 | 1,969 | |
Aug 09 2019 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 190.41 | 26,581 | 5,061,288 | 26,581 | |
Aug 09 2019 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 190.41 | 19,936 | 3,796,014 | 19,936 | |
Aug 09 2019 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 0.00 | 3,938 | 0 | 3,938 | |
Aug 09 2019 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Option Exercise | A | 190.41 | 15,948 | 3,036,659 | 15,948 | |
Aug 09 2019 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Option Exercise | A | 190.41 | 11,961 | 2,277,494 | 11,961 | |
Aug 09 2019 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Option Exercise | A | 0.00 | 2,363 | 0 | 2,363 | |
Aug 09 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 190.41 | 57,150 | 10,881,932 | 57,150 | |
Aug 09 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 190.41 | 85,725 | 16,322,897 | 85,725 | |
Aug 09 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 0.00 | 16,937 | 0 | 16,937 | |
Aug 09 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Grant | A | 0.00 | 11,291 | 0 | 103,467 | 92.2 K to 103.5 K (+12.25 %) |
Jul 12 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 67.46 | 16,969 | 1,144,729 | 0 | |
Jul 12 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 214.07 | 494 | 105,750 | 92,176 | 92.7 K to 92.2 K (-0.53 %) |
Jul 12 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 213.32 | 9,909 | 2,113,768 | 92,670 | 102.6 K to 92.7 K (-9.66 %) |
Jul 12 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 212.75 | 6,566 | 1,396,911 | 102,579 | 109.1 K to 102.6 K (-6.02 %) |
Jul 12 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 67.46 | 16,969 | 1,144,729 | 109,145 | 92.2 K to 109.1 K (+18.41 %) |
Jul 10 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 67.46 | 15,037 | 1,014,396 | 16,969 | |
Jul 10 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 67.46 | 17,994 | 1,213,875 | 32,006 | |
Jul 10 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 212.43 | 15,037 | 3,194,340 | 92,176 | 107.2 K to 92.2 K (-14.03 %) |
Jul 10 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 67.46 | 15,037 | 1,014,396 | 107,213 | 92.2 K to 107.2 K (+16.31 %) |
Jul 10 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 212.75 | 17,994 | 3,828,184 | 92,176 | 110.2 K to 92.2 K (-16.33 %) |
Jul 10 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 67.46 | 17,994 | 1,213,875 | 110,170 | 92.2 K to 110.2 K (+19.52 %) |
Jul 10 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 67.46 | 15,037 | 1,014,396 | 16,969 | |
Jul 10 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 67.46 | 17,994 | 1,213,875 | 32,006 | |
Jul 10 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 212.43 | 15,037 | 3,194,340 | 92,176 | 107.2 K to 92.2 K (-14.03 %) |
Jul 10 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 67.46 | 15,037 | 1,014,396 | 107,213 | 92.2 K to 107.2 K (+16.31 %) |
Jul 10 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 212.75 | 17,994 | 3,828,184 | 92,176 | 110.2 K to 92.2 K (-16.33 %) |
Jul 10 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 67.46 | 17,994 | 1,213,875 | 110,170 | 92.2 K to 110.2 K (+19.52 %) |
Jul 02 2019 | TECH | BIO-TECHNE Corp | VESSEY RUPERT | Option Exercise | A | 209.26 | 588 | 123,045 | 588 | ||
Jul 02 2019 | TECH | BIO-TECHNE Corp | VESSEY RUPERT | Grant | A | 0.00 | 147 | 0 | 147 | 0 to 147 | |
Jun 14 2019 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Sell | S | 215.00 | 3,117 | 670,155 | 0 | 3.1 K to 0 (-100.00 %) |
Jun 06 2019 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Option Exercise | M | 63.03 | 5,000 | 315,150 | 0 | ||
Jun 06 2019 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Sell | S | 203.67 | 5,000 | 1,018,346 | 3,526 | 8.5 K to 3.5 K (-58.64 %) | |
Jun 06 2019 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Buy | M | 63.03 | 5,000 | 315,150 | 8,526 | 3.5 K to 8.5 K (+141.80 %) | |
May 29 2019 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | M | 94.35 | 5,400 | 509,490 | 5,400 | |
May 29 2019 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 200.00 | 5,400 | 1,080,000 | 2,189 | 7.6 K to 2.2 K (-71.16 %) |
May 29 2019 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Buy | M | 0.00 | 5,400 | 0 | 7,589 | 2.2 K to 7.6 K (+246.69 %) |
May 02 2019 | TECH | BIO-TECHNE Corp | Kelderman Kim | President, Diagnost ... | Option Exercise | M | 0.00 | 1,667 | 0 | 0 | |
May 02 2019 | TECH | BIO-TECHNE Corp | Kelderman Kim | President, Diagnost ... | Payment of Exercise | F | 202.13 | 844 | 170,598 | 823 | 1.7 K to 823 (-50.63 %) |
May 02 2019 | TECH | BIO-TECHNE Corp | Kelderman Kim | President, Diagnost ... | Buy | M | 202.13 | 1,667 | 336,951 | 1,667 | 0 to 1.7 K |
May 02 2019 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 86.25 | 25,000 | 2,156,250 | 0 | |
May 02 2019 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 86.25 | 10,000 | 862,500 | 0 | |
May 02 2019 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 203.08 | 35,000 | 7,107,681 | 4,382 | 39.4 K to 4.4 K (-88.87 %) |
May 02 2019 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 86.25 | 35,000 | 3,018,750 | 39,382 | 4.4 K to 39.4 K (+798.72 %) |
Oct 29 2018 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Option Exercise | A | 179.84 | 1,898 | 341,336 | 1,898 | ||
Oct 29 2018 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Grant | A | 0.00 | 514 | 0 | 4,226 | 3.7 K to 4.2 K (+13.85 %) | |
Oct 29 2018 | TECH | BIO-TECHNE Corp | Seth Alpna | Option Exercise | A | 179.84 | 1,898 | 341,336 | 1,898 | ||
Oct 29 2018 | TECH | BIO-TECHNE Corp | Seth Alpna | Grant | A | 0.00 | 514 | 0 | 1,253 | 739 to 1.3 K (+69.55 %) | |
Oct 29 2018 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Option Exercise | A | 179.84 | 1,898 | 341,336 | 1,898 | ||
Oct 29 2018 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Grant | A | 0.00 | 514 | 0 | 4,726 | 4.2 K to 4.7 K (+12.20 %) | |
Oct 29 2018 | TECH | BIO-TECHNE Corp | Nusse Roeland | Option Exercise | A | 179.84 | 1,898 | 341,336 | 1,898 | ||
Oct 29 2018 | TECH | BIO-TECHNE Corp | Nusse Roeland | Grant | A | 0.00 | 514 | 0 | 5,226 | 4.7 K to 5.2 K (+10.91 %) | |
Oct 29 2018 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Option Exercise | A | 179.84 | 1,898 | 341,336 | 1,898 | ||
Oct 29 2018 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Grant | A | 0.00 | 514 | 0 | 1,253 | 739 to 1.3 K (+69.55 %) | |
Oct 29 2018 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Option Exercise | A | 179.84 | 1,898 | 341,336 | 1,898 | ||
Oct 29 2018 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Grant | A | 0.00 | 514 | 0 | 3,526 | 3 K to 3.5 K (+17.07 %) | |
Oct 29 2018 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Option Exercise | A | 179.84 | 1,898 | 341,336 | 1,898 | ||
Oct 29 2018 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Grant | A | 0.00 | 514 | 0 | 8,226 | 7.7 K to 8.2 K (+6.66 %) | |
Aug 31 2018 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Payment of Exercise | F | 180.50 | 1,338 | 241,509 | 92,176 | 93.5 K to 92.2 K (-1.43 %) |
Aug 28 2018 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Option Exercise | M | 61.46 | 5,000 | 307,300 | 0 | ||
Aug 28 2018 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Sell | S | 188.47 | 5,000 | 942,334 | 7,712 | 12.7 K to 7.7 K (-39.33 %) | |
Aug 28 2018 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Buy | M | 61.46 | 5,000 | 307,300 | 12,712 | 7.7 K to 12.7 K (+64.83 %) | |
Aug 27 2018 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Option Exercise | M | 61.08 | 10,000 | 610,800 | 0 | |
Aug 27 2018 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Sell | S | 187.92 | 10,000 | 1,879,173 | 3,012 | 13 K to 3 K (-76.85 %) |
Aug 27 2018 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Buy | M | 61.08 | 10,000 | 610,800 | 13,012 | 3 K to 13 K (+332.01 %) |
Aug 10 2018 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Option Exercise | M | 63.06 | 5,000 | 315,300 | 0 | ||
Aug 10 2018 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Sell | S | 176.94 | 5,000 | 884,675 | 8,212 | 13.2 K to 8.2 K (-37.84 %) | |
Aug 10 2018 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Buy | M | 63.03 | 5,000 | 315,150 | 13,212 | 8.2 K to 13.2 K (+60.89 %) | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 177.32 | 90,334 | 16,018,025 | 90,334 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 177.32 | 60,222 | 10,678,565 | 60,222 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 0.00 | 16,918 | 0 | 16,918 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | D | 108.49 | 23,929 | 2,596,057 | 95,346 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | D | 0.00 | 3,467 | 0 | 0 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 0.00 | 13,816 | 0 | 3,467 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Grant | A | 0.00 | 11,279 | 0 | 93,514 | 82.2 K to 93.5 K (+13.72 %) |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Payment of Exercise | F | 180.14 | 1,752 | 315,605 | 82,235 | 84 K to 82.2 K (-2.09 %) |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Payment of Exercise | F | 180.14 | 6,301 | 1,135,062 | 83,987 | 90.3 K to 84 K (-6.98 %) |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 0.00 | 13,816 | 0 | 90,288 | 76.5 K to 90.3 K (+18.07 %) |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | A | 177.32 | 13,550 | 2,402,686 | 13,550 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | A | 177.32 | 18,066 | 3,203,463 | 18,066 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | A | 0.00 | 2,537 | 0 | 2,537 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | D | 108.49 | 1,881 | 204,070 | 7,494 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | D | 0.00 | 301 | 0 | 0 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | M | 0.00 | 1,199 | 0 | 301 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Payment of Exercise | F | 180.14 | 348 | 62,689 | 3,117 | 3.5 K to 3.1 K (-10.04 %) |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Buy | M | 0.00 | 1,199 | 0 | 3,465 | 2.3 K to 3.5 K (+52.91 %) |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 177.32 | 7,339 | 1,301,351 | 7,339 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 177.32 | 9,786 | 1,735,254 | 9,786 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 0.00 | 1,374 | 0 | 1,374 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | D | 108.49 | 1,505 | 163,277 | 5,995 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | D | 0.00 | 241 | 0 | 0 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | M | 0.00 | 959 | 0 | 241 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Payment of Exercise | F | 180.14 | 438 | 78,901 | 2,189 | 2.6 K to 2.2 K (-16.67 %) |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Buy | M | 0.00 | 959 | 0 | 2,627 | 1.7 K to 2.6 K (+57.49 %) |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 177.32 | 18,066 | 3,203,463 | 18,066 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 177.32 | 24,089 | 4,271,461 | 24,089 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 0.00 | 3,383 | 0 | 3,383 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | D | 108.49 | 3,762 | 408,139 | 14,988 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | D | 0.00 | 602 | 0 | 0 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,398 | 0 | 602 | |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Payment of Exercise | F | 180.14 | 1,094 | 197,073 | 4,382 | 5.5 K to 4.4 K (-19.98 %) |
Aug 09 2018 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 0.00 | 2,398 | 0 | 5,477 | 3.1 K to 5.5 K (+77.88 %) |
Jun 08 2018 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 160.00 | 8,000 | 1,280,000 | 76,472 | 84.5 K to 76.5 K (-9.47 %) |
May 03 2018 | TECH | BIO-TECHNE Corp | Kelderman Kim | President, Diagnost ... | Option Exercise | A | 150.78 | 7,348 | 1,107,931 | 10,000 | |
May 03 2018 | TECH | BIO-TECHNE Corp | Kelderman Kim | President, Diagnost ... | Option Exercise | A | 150.78 | 2,652 | 399,869 | 2,652 | |
May 03 2018 | TECH | BIO-TECHNE Corp | Kelderman Kim | President, Diagnost ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Feb 15 2018 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Director | Option Exercise | M | 65.47 | 5,000 | 327,350 | 0 | |
Feb 15 2018 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Director | Sell | S | 136.36 | 2,505 | 341,582 | 8,212 | 10.7 K to 8.2 K (-23.37 %) |
Feb 15 2018 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Director | Sell | S | 135.76 | 2,495 | 338,721 | 10,717 | 13.2 K to 10.7 K (-18.88 %) |
Feb 15 2018 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Director | Buy | M | 65.47 | 5,000 | 327,350 | 13,212 | 8.2 K to 13.2 K (+60.89 %) |
Nov 03 2017 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Option Exercise | M | 63.03 | 5,000 | 315,150 | 0 | ||
Nov 03 2017 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Sell | S | 130.18 | 5,000 | 650,907 | 7,712 | 12.7 K to 7.7 K (-39.33 %) | |
Nov 03 2017 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Buy | M | 63.03 | 5,000 | 315,150 | 12,712 | 7.7 K to 12.7 K (+64.83 %) | |
Oct 31 2017 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Option Exercise | A | 125.05 | 3,125 | 390,781 | 3,125 |